Skip to main content
OpenTrials
Completed

NCT Number: NCT04785209

Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.

Predicting no reflow in ppci of STEMI patients using mean platelet volume together with STEMI clinical risk scores

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Assiut university hospital

Asyut, 71515, Egypt

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients presenting with acute STEMI, within 24 hours of symptoms, fulfilling criteria for PPCI protocol in our facility

Exclusion criteria

  • patients presenting more than 24 hours of symptoms onset
  • patients not eligible for PPCI program in our facility

Treatment and study plan

Mean platelet volume, lymphocyte number, STEMI clinical risk scores

Other

Lab parameters

Primary outcomes

  1. Number of participents with No reflow after PPCI and in hospital mortality

    Time frame: Within 48 hours from admission

    No reflow: suboptimal myocardial reperfusion through a part of coronary circulation without angiographic evidence of mechanical vessel obstruction.

    In hospital mortality

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute STEMI Patients Undergoing PPCI.

Important dates

Study start
2020
Primary completion
2021
Study completion
2024
First posted
Mar 5, 2021
Registry last updated
May 31, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.